Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanocortin-2 receptor accessory protein (MRAP) is a small, single-pass transmembrane protein that forms antiparallel homodimers with a unique dual topology—both its N- and C-termini can be oriented extracellularly. MRAP is absolutely required for the functional expression of the melanocortin-2 receptor (MC2R, or ACTH receptor): it traffics MC2R from the endoplasmic reticulum to the plasma membrane, enabling receptor glycosylation, ACTH binding, and downstream signaling via cAMP. Without MRAP, MC2R is retained in the ER and fails to respond to ACTH, resulting in familial glucocorticoid deficiency. MRAP expression is found in adrenal cortex, lymph nodes, brain, testis, breast, thyroid, and adipose tissue, and is regulated by ACTH and other signals. It is not itself a classical receptor, enzyme, or drug target but is indispensable for MC2 receptor function, making it a critical molecular chaperone and accessory protein.
Not directly drug-targeted; essential for MC2 receptor function, which mediates ACTH-induced cAMP signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin-2 receptor accessory protein (MRAP).